In 2009, Fogelgren et al. demonstrated that Six-2 gene expression is reduced during fetal ontogenesis when associated with decreased nephron numbers, hypertension, and chronic renal failure [77]. This evidence concerns the gene SIX2 and chronic kidney disease.